Form 4: Encompass Health Director Joan E. Herman Reports Acquisition of Restricted Stock Units Due to Dividend Payment
SEC Filing (Form 4)
Director Joan E. Herman reports acquiring 81 restricted stock units of Encompass Health Corp due to a dividend payment.
Summary
- On October 17, 2024, Joan E. Herman, a director of Encompass Health Corp, filed a Form 4 with the SEC.
- The form reports the acquisition of 81 restricted stock units (RSUs) on October 15, 2024, due to a dividend payment.
- These RSUs were credited to Herman's account as a non-employee director in connection with common stock dividend payments.
- The dividend paid was $0.17 per share, and the closing price of Encompass Health's common stock on the dividend payment date was $96.33.
- Following the transaction, Herman beneficially owns 46,022 shares of Encompass Health common stock.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, indicating stability and alignment of interests. The sentiment is neutral to slightly positive.
Positives
- The acquisition of RSUs due to dividend payments is a standard practice for non-employee directors, indicating a consistent compensation structure.
- The director's continued holding of a significant number of shares (46,022) suggests confidence in the company's future.
Industry Context
Directors receiving stock-based compensation, including RSUs related to dividend payments, is a common practice in publicly traded companies to align their interests with those of shareholders.
Comparison to Industry Standards
- Stock-based compensation for directors is a standard practice across the healthcare industry, including companies like Universal Health Services and HCA Healthcare.
- Dividend payments and the subsequent allocation of RSUs are typical methods for compensating non-employee directors, ensuring their interests are aligned with shareholders.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders by aligning the director's interests with dividend payouts.
Key Dates
| Date | Description |
|---|---|
| 10/15/2024 | Date of the transaction (acquisition of RSUs) and dividend payment. |
| 10/17/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.